When Pain Medications Interfere with Physical Therapy Success

August 2025 – Every medication decision is a mobility decision! As pharmacists, we often see unintended consequences of well-meaning prescriptions. One concerning pattern involves gabapentin timing that can undermine physical therapy outcomes—precisely when patients need cognitive abilities most for motor learning.

The Hidden Cognitive Impact

Recent research reveals gabapentin creates measurable deficits in memory, executive function, and attention within one week of starting therapy. For patients beginning physical therapy, this creates a perfect storm: pain relief comes at the cost of reduced ability to learn movement patterns, follow instructions, and remember safety techniques.

Studies show patients struggle to “follow and remember instructions from therapies,” leading to prolonged rehabilitation. When facilities track progress through outcome measures, gabapentin timing becomes a quality issue—patients plateau not due to their condition, but because cognitive capacity for motor learning is compromised.

Beyond Gabapentin: Other Mobility-Affecting Medications

Several drug classes create similar challenges:

• Central Nervous System Suppressors: Benzodiazepines, antipsychotics, and other anticonvulsants impair balance, reaction time, and coordination—exactly what physical therapy aims to improve.
• Blood Pressure Medications: ACE inhibitors and diuretics can cause orthostatic hypotension, creating dizziness during position changes crucial for mobility training.
• Muscle-Weakening Medications: Corticosteroids and certain diuretics directly counteract strength-building goals through muscle wasting and electrolyte imbalances.

Practical Solutions for Patients, Pharmacists, & Physical Therapists

• Timing Interventions: Advocate for bedtime dosing to minimize daytime cognitive effects during therapy. Coordinate with rehabilitation teams to optimize learning windows.
• Dose Optimization: Work with prescribers to find minimum effective doses providing symptom relief without cognitive impairment.
• Patient Education: Help patients understand the medication-mobility connection and recognize medication-related versus condition-related symptoms.

Remember: Every medication decision is a mobility decision. By optimizing timing, dosing, and selection of therapies, we can ensure prescriptions support rather than adversely affect functional recovery goals.